Low Frequency Electromagnetic Field Conditioning Protects against I/R Injury and Contractile Dysfunction in the Isolated Rat Heart.
Abstract
Low frequency electromagnetic field (LF-EMF) decreases the formation of reactive oxygen species, which are key mediators of ischemia/reperfusion (I/R) injury. Therefore, we hypothesized that the LF-EMF protects contractility of hearts subjected to I/R injury. Isolated rat hearts were subjected to 20 min of global no-flow ischemia, followed by 30 min reperfusion, in the presence or absence of LF-EMF. Coronary flow, heart rate, left ventricular developed pressure (LVDP), and rate pressure product (RPP) were determined for evaluation of heart mechanical function. The activity of cardiac matrix metalloproteinase-2 (MMP-2) and the contents of coronary effluent troponin I (TnI) and interleukin-6 (IL-6) were measured as markers of heart injury. LF-EMF prevented decreased RPP in I/R hearts, while having no effect on coronary flow. In addition, hearts subjected to I/R exhibited significantly increased LVDP when subjected to LF-EMF. Although TnI and IL-6 levels were increased in I/R hearts, their levels returned to baseline aerobic levels in I/R hearts subjected to LF-EMF. The reduced activity of MMP-2 in I/R hearts was reversed in hearts subjected to LF-EMF. The data presented here indicate that acute exposure to LF-EMF protects mechanical function of I/R hearts and reduces I/R injury.
AI evidence extraction
Main findings
In isolated rat hearts subjected to ischemia/reperfusion, LF-EMF exposure prevented a decrease in rate pressure product and increased LVDP, with no effect on coronary flow. Elevated TnI and IL-6 in I/R hearts returned to baseline levels with LF-EMF, and reduced MMP-2 activity in I/R hearts was reversed by LF-EMF.
Outcomes measured
- Heart mechanical function (coronary flow
- heart rate
- left ventricular developed pressure (LVDP)
- rate pressure product (RPP))
- Markers of heart injury (troponin I (TnI)
- interleukin-6 (IL-6))
- Cardiac matrix metalloproteinase-2 (MMP-2) activity
Limitations
- Frequency and field strength/dose parameters of LF-EMF not reported in the abstract
- Ex vivo isolated rat heart model
- generalizability to in vivo or humans not addressed in the abstract
- Sample size not provided in the abstract
View raw extracted JSON
{
"study_type": "animal",
"exposure": {
"band": "ELF",
"source": null,
"frequency_mhz": null,
"sar_wkg": null,
"duration": "acute; during 20 min ischemia and 30 min reperfusion (isolated rat heart I/R protocol)"
},
"population": "Isolated rat hearts (ex vivo)",
"sample_size": null,
"outcomes": [
"Heart mechanical function (coronary flow, heart rate, left ventricular developed pressure (LVDP), rate pressure product (RPP))",
"Markers of heart injury (troponin I (TnI), interleukin-6 (IL-6))",
"Cardiac matrix metalloproteinase-2 (MMP-2) activity"
],
"main_findings": "In isolated rat hearts subjected to ischemia/reperfusion, LF-EMF exposure prevented a decrease in rate pressure product and increased LVDP, with no effect on coronary flow. Elevated TnI and IL-6 in I/R hearts returned to baseline levels with LF-EMF, and reduced MMP-2 activity in I/R hearts was reversed by LF-EMF.",
"effect_direction": "benefit",
"limitations": [
"Frequency and field strength/dose parameters of LF-EMF not reported in the abstract",
"Ex vivo isolated rat heart model; generalizability to in vivo or humans not addressed in the abstract",
"Sample size not provided in the abstract"
],
"evidence_strength": "low",
"confidence": 0.78,
"peer_reviewed_likely": "yes",
"keywords": [
"low frequency electromagnetic field",
"LF-EMF",
"ELF",
"ischemia/reperfusion",
"isolated rat heart",
"contractile dysfunction",
"reactive oxygen species",
"troponin I",
"interleukin-6",
"MMP-2",
"rate pressure product",
"left ventricular developed pressure"
],
"suggested_hubs": []
}AI can be wrong. Always verify against the paper.
Comments
Log in to comment.
No comments yet.
NNEMF synthesis
Synthesis pending.